- Home
- PSA vs TAK Comparison
PSA vs TAK Comparison
Compare PSA & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSA | TAK |
|---|---|---|
| Founded | 1972 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4B | 43.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PSA | TAK |
|---|---|---|
| Price | $271.21 | $14.57 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $316.75 | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 2.6M |
| Earning Date | 10-29-2025 | 01-29-2026 |
| Dividend Yield | ★ 4.36% | 3.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.63 | 0.14 |
| Revenue | $4,795,182,000.00 | ★ $29,846,840,032.00 |
| Revenue This Year | $1.81 | N/A |
| Revenue Next Year | $3.56 | $0.59 |
| P/E Ratio | ★ $28.55 | $102.85 |
| Revenue Growth | ★ 2.06 | N/A |
| 52 Week Low | $256.60 | $12.80 |
| 52 Week High | $326.70 | $15.69 |
Technical Indicators
Market Signals| Indicator | PSA | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 61.62 |
| Support Level | $264.60 | $14.20 |
| Resistance Level | $277.39 | $14.53 |
| Average True Range (ATR) | 4.74 | 0.14 |
| MACD | 0.77 | 0.01 |
| Stochastic Oscillator | 46.47 | 98.81 |
Price Performance
Historical ComparisonAbout PSA Public Storage
Public Storage is the largest owner of self-storage facilities in the US, with more than 3,300 self-storage facilities in 40 states and approximately 245 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage. The company also has a merchandise business, a third-party property management business, and an insurance business that offers products to cover losses for the goods in self-storage facilities.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.